Nicholas Boyd-Gibbins, MEng, PhD (@nboydgibbins) 's Twitter Profile
Nicholas Boyd-Gibbins, MEng, PhD

@nboydgibbins

UCL | Kyoto Univ. | CSO | cell engineering, cell therapy, immunotherapy, autoimmune, long COVID, iPSCs, cancer, genetics and neuroscience
@amaticahealth

ID: 594682448

calendar_today30-05-2012 15:37:00

1,1K Tweet

2,2K Takipçi

638 Takip Edilen

Nicholas Boyd-Gibbins, MEng, PhD (@nboydgibbins) 's Twitter Profile Photo
Nicholas Boyd-Gibbins, MEng, PhD
@nboydgibbins

2 years ago

Would long Covid or ME/CFS patients pay £285 ($350) to cover the cost of their own sample in a biomarker study? We will be able to receive our results which will be explained The biomarker has very high performance at small scale. It should only get stronger with more samples